Psychology by BogdanovaThe Encyclopedia of Psychology for the Artificial Era

RESEARCH DOSSIER

Psychoneuroimmunology and Stress-Related Disease Susceptibility

Abstract. Psychoneuroimmunology examines reciprocal interactions between psychological experience, neural and endocrine activity, immune regulation, and behavior. This fundamental research monograph investigates how stress exposures may alter susceptibility to infection, inflammatory disorders, and impaired tissue repair through experimentally measurable mechanisms. The synthesis traces foundational work on conditioned immunity, neuroimmune signaling, human viral challenge, vaccination, and wound healing; analyzes glucocorticoid sensitivity, leukocyte trafficking, cytokine responses, social-genomic pathways, sleep, and developmental adversity; and critically evaluates causal inference, immune-assay validity, longitudinal research, and randomized psychosocial interventions. Historical experiments are integrated with peer-reviewed research and systematic syntheses published through 2026, including contemporary neuroimmune circuit investigations and disease-specific evidence. The central finding is that stress-related immune effects depend on timing, host condition, immune compartment, and outcome definition. Controlled infection and repair paradigms provide functional evidence in defined settings, whereas isolated immune biomarkers cannot independently establish prevention or causation of a particular disease. The analysis differentiates established signaling pathways, experimentally demonstrated responses, prospective clinical associations, plausible mediation models, and unresolved clinical translation. The work is a critical narrative scholarly synthesis of existing research, with no new participants, original meta-analysis, or PRISMA systematic-review claim. Its future research orientation includes testable effects of human–Artificial interaction on human stress biology, without presupposing immune outcomes.

Keywords: psychoneuroimmunology; psychological stress; disease susceptibility; neuroimmune communication; immunoregulation; infection risk; viral challenge; host resistance; glucocorticoid receptor resistance; cytokines; inflammation; sympathetic nervous system; hypothalamic-pituitary-adrenal axis; leukocyte trafficking; vaccination; antibody response; wound healing; biological embedding; chronic adversity; sleep; social ties; sickness behavior; immune assays; stress reactivity; randomized psychosocial interventions; causal inference; immune biomarkers; clinical translation; Artificial Era.

Scientific Overview and Research Object

Psychoneuroimmunology investigates reciprocal relations among psychological experience, nervous-system activity, endocrine regulation, immune processes, and behavior. Its central premise is experimentally tractable: stimuli that acquire psychological significance can engage neural and peripheral signaling pathways that alter measurable immune activity, while immune mediators can in turn change neural function, motivation, mood, and conduct. The present research dossier examines one particularly consequential part of that field: how stress-related exposures and adaptations modify susceptibility to infection, inflammatory disease processes, tissue repair, and other clinically defined outcomes. The central object is a causal network linking stressful circumstances with immune regulation and disease vulnerability, considered at the level of measurable pathways and explicitly specified health endpoints.

Stress-related disease susceptibility is the conditional probability of developing a specified pathological outcome, given a defined exposure and population, as it may be altered by stressful experience and associated biological or behavioral processes. The definition requires a denominator, a period of observation, and a meaningful disease definition. A higher circulating inflammatory marker, reduced lymphocyte proliferation, slower wound closure, and a laboratory-confirmed respiratory infection are scientifically different endpoints. A hypothesis about one does not automatically establish an effect on another. The distinction is essential because much of the literature addresses surrogate immune outcomes, while the strongest direct human evidence comes from controlled viral-challenge studies, vaccine-response experiments, and wound-healing protocols.

The landmark investigation by Cohen, S., Tyrrell, D. A. J., & Smith, A. P (1991) prospectively assessed psychological stress before controlled administration of respiratory viruses, making the clinical illness outcome observable independently of ordinary differences in community exposure. Segerstrom, S. C., & Miller, G. E (2004) later integrated more than 300 empirical articles and showed that associations depend decisively on whether stress is acute, time-limited, or chronic and on which immune parameter is studied. Together, these works demonstrate why the subject cannot be reduced to the idea that stress invariably weakens immunity. Short-term mobilization, prolonged inflammatory activation, reduced antiviral signaling, and altered recovery may occur in different tissues and phases of a response.

The research questions pursued here are how psychoneuroimmune communication became an experimental science; how stress exposures reach immune cells; which immune changes are adaptive, dysregulated, or merely measurable; what controlled studies establish about infection, vaccination, and repair; how psychosocial adversity becomes biologically embedded; what randomized psychosocial interventions can actually change; and which explanations survive careful appraisal of confounding, biological timing, measurement error, replication, and clinical relevance. The method is a critical narrative synthesis of original experimental studies, mechanistic reports, longitudinal observations, systematic reviews, and selected clinical evidence. It introduces no new participants, pooled estimates, diagnostic criteria, or claims of a completed PRISMA review.

Foundational Definitions and Levels of Explanation

The immune system comprises interacting innate and adaptive defenses, tissue-resident cells, circulating leukocytes, soluble mediators, and regulatory mechanisms that preserve host function while responding to threats. Innate responses include barrier defenses, phagocytic activity, innate lymphoid responses, and inflammatory signaling; adaptive responses involve antigen-specific B- and T-cell functions and immunological memory. Inflammation is a coordinated response that can protect tissues and support repair, but sustained or misdirected inflammatory activity can contribute to pathology. Consequently, a scientific claim that an immune measure has increased must identify which function increased and whether the observed change represents protection, activation, compensation, or injury.

Psychological stress refers to processes arising when events or conditions are appraised, experienced, or organized as demanding, threatening, uncontrollable, or costly relative to available resources. Acute stressors, repeated daily demands, chronic caregiving burdens, social isolation, early adversity, sleep loss, and severe trauma differ in temporal organization and associated physiological demands. They should be measured with instruments appropriate to their causal hypotheses. Perceived stress, life-event exposure, laboratory challenge, chronic role burden, and objective deprivation are not interchangeable indicators. Stress physiology also includes responses to events that a participant may not label as stressful.

Psychoneuroimmune pathways can be examined at several levels. The neural level includes autonomic outflow and central threat processing. The endocrine level includes hypothalamic-pituitary-adrenal signaling and glucocorticoid feedback. The cellular level includes leukocyte trafficking, immune-receptor signaling, cytokine production, and the sensitivity of immune cells to hormonal regulation. The genomic level concerns patterns of transcription in immune cells. The behavioral level includes sleep, physical activity, smoking, social contact, diet, infection exposure, and treatment engagement. The clinical level concerns documented disease or healing, which may occur long after the initiating stressor.

The system is bidirectional. Irwin, M. R., & Cole, S. W (2011) described reciprocal regulation of neural and innate immune activity; Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W (2008) detailed routes by which inflammatory signals influence brain processes and sickness behavior. Accordingly, a correlation between distress and inflammation can reflect stress-to-immune effects, immune-to-brain effects, common environmental causes, or their feedback. Model specification requires temporal sampling and tests that discriminate among these possibilities.

The term susceptibility is therefore reserved for a disease-specific endpoint or a rigorously defined component of host defense. Changes in cortisol, C-reactive protein, interleukin-6, or gene expression are mechanistic observations; their clinical interpretation depends on context, timing, and evidence linking them to the specified disorder. This terminological discipline protects scientific inference from overstating what biomarker studies establish.

Historical Formation of Psychoneuroimmunology

The historical emergence of psychoneuroimmunology was an accumulation of experimental demonstrations that learning, neuroendocrine activity, and immunity belong to an integrated regulatory organization. The influential conditioning experiments of Ader, R., & Cohen, N (1975) paired a saccharin taste with an immunosuppressive drug in rats and subsequently demonstrated conditioned changes in antibody response. The design supplied an experimentally manipulable bridge between associative learning and a measurable immune endpoint. It did not imply that ordinary human thoughts can voluntarily reproduce a drug's effects; its importance was to challenge an isolated conception of immunity by showing a learning-dependent effect under defined animal conditions.

A parallel neuroimmune research line investigated how immune activation influences the brain. Besedovsky, H., Sorkin, E., Keller, M., & Müller, J (1975) described changes in circulating hormones during experimental immune responses in animals. Besedovsky, H., Sorkin, E., Felix, D., & Haas, H (1977) then reported hypothalamic neuronal changes during antigenic challenge, supplying evidence for immune-to-neural signaling. The reciprocal perspective expanded the field from psychological influences on immunity to the larger study of mutually regulating organismic systems.

Human research subsequently moved beyond small laboratory immune-assay demonstrations toward clinically meaningful endpoints. Cohen, S., Tyrrell, D. A. J., & Smith, A. P (1991) investigated infection and clinical colds after experimentally controlled viral exposure. Kiecolt-Glaser and colleagues (1995)92899-5) evaluated wound closure in stressed caregivers and matched comparison participants. Vaccine-response studies, including work on caregiving and influenza immunization and Vedhara and colleagues (1999)06098-X), made functional antibody outcomes central to the developing field.

The disciplinary history also includes a transition from broad suppression narratives to temporal and molecular differentiation. Reviews by Kiecolt-Glaser, J. K., McGuire, L., Robles, T. F., & Glaser (2002) and Glaser, R., & Kiecolt-Glaser, J. K (2005) organized accumulating evidence concerning stressors, immune measures, and health consequences. The meta-analysis by Segerstrom, S. C., & Miller, G. E (2004) changed the explanatory center by distinguishing stressor duration and immune domain. Later experimental and genomic studies investigated glucocorticoid resistance, inflammatory transcription, and social-threat signaling.

The historical record supports a practical methodological lesson. A mechanistic hypothesis becomes stronger when multiple operationally independent methods converge, but it does not become an unlimited assertion about disease. The history of psychoneuroimmunology is best read through the successive development of interventions, biological assays, controlled exposure, prospective designs, and clinically relevant outcomes.

Behavioral Conditioning and Immune Modulation

Classical conditioning offers a distinctive mechanism because it shows that an acquired environmental cue can come to influence physiological responses after a prior pairing with a biological agent. In the original Ader, R., & Cohen, N (1975), saccharin was paired with cyclophosphamide, an immunosuppressive drug, and subsequent immune responses were compared across controlled conditions. The critical inference concerned learned modulation of an antibody response in animals. The endpoint was experimentally measured rather than inferred from behavioral appearance alone.

Three distinctions clarify the significance of this evidence. First, a conditioned response is an acquired relation involving prior exposure, not proof that immune mechanisms are directly governed by conscious intention. Second, the pharmacological unconditioned stimulus has complex physiological effects; learned changes are therefore interpreted relative to its properties and the specific conditioning paradigm. Third, antibody production is one component of immunity, and a result involving a particular experimental antigen does not transfer automatically to broad disease protection or vulnerability.

Conditioned immune effects also highlight problems of experimental control. Investigators must distinguish learned responses from residual drug exposure, altered intake, stress associated with procedures, changes in general activity, and the possibility that the conditioned cue has independent properties. Proper experimental groups, exposure schedules, and assays are indispensable. The logic of controls developed in behavioral immunology therefore anticipated later concern about interpreting psychosocial influences on broad immune panels.

Human investigations into expectation, placebo phenomena, and conditioned physiological responses raise related questions but require independently established evidence. A participant's expectation can alter perceived symptoms without necessarily altering viral replication, inflammatory injury, or antigen-specific immunity. Biological conditioning and symptom appraisal may interact, yet a finding in one domain does not prove a clinical intervention in another. The credible implication of foundational conditioning work is that learned environmental information can enter immune regulation through organismic signaling, a proposition that remains subject to experimental definition.

For this dossier, learning-dependent immune modulation is a historical foundation and a potential source of mechanistic hypotheses. The main inquiry concerns more sustained patterns of stress-related disease susceptibility, which demand additional evidence concerning exposure, time, and clinically specified endpoints.

Reciprocal Neuroimmune Communication

Communication from the nervous system toward immune tissue occurs through neural and endocrine routes. Sympathetic activity and its mediators can influence cellular trafficking, antigen presentation, cytokine production, and gene expression. Glucocorticoids released through hypothalamic-pituitary-adrenal signaling regulate numerous immune processes, with effects dependent on concentration, receptor sensitivity, exposure duration, and cellular environment. These mechanisms do not produce a uniform direction of change across every immune compartment.

Communication from the immune system toward the brain is equally consequential. Cytokines and other inflammatory mediators can alter neural activity through humoral signaling, afferent nerves, and cellular pathways associated with brain barriers and interfaces. Besedovsky, H., Sorkin, E., Felix, D., & Haas, H (1977) provided early experimental evidence of hypothalamic responses to antigenic challenge. Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W (2008) later synthesized evidence for sickness behavior, including altered fatigue, activity, appetite, and social motivation during immune activation.

The implications for observational research are profound. Consider a person with fatigue, low mood, sleep disruption, and raised inflammatory markers. A stress-first explanation is possible, but an immune-driven behavioral state, an infection, a metabolic condition, or other common causes may explain the same pattern. Without appropriate timing and biomedical assessment, psychological distress should not be treated as the initiating cause. The explanatory direction is itself a research question.

Irwin, M. R., & Cole, S. W (2011) described neuroimmune regulation as a circuit that integrates environmental interpretation with leukocyte transcription and feedback to the central nervous system. This formulation locates psychological events in a network of physically mediated signaling rather than as mysterious direct actions on immune cells. It also draws attention to compensatory responses: inflammation may help restore homeostasis during infection while inducing behavioral changes that promote rest; under chronic or excessive activation the same systems may contribute to pathology.

A well-designed psychoneuroimmune study therefore specifies the trigger, signaling route, immune readout, clinical endpoint, and sampling interval. Each transition requires evidence. The existence of neural–immune communication is an established physiological foundation; the relative importance of a particular pathway in a particular disease remains empirically contingent.

Psychological Appraisal and the Organization of Stress Exposure

The same objectively observable event can have different behavioral and physiological implications depending on controllability, predictability, social meaning, prior experience, and available resources. Appraisal theory supplies a vocabulary for interpreting these differences, but perceived threat remains a psychological construct that must be measured, and its proposed biological consequences must be tested. Researchers can assess daily stress, chronic roles, interpersonal conflict, perceived isolation, or experimentally elicited evaluative threat, with different biases and temporal resolution.

A central question is whether stress exposure is best understood as a discrete event, a chronic environment, or the sequence connecting experiences over time. A short laboratory challenge can be standardized and repeated; a prolonged caregiving burden may involve disturbed sleep, financial strain, recurring threat, and changes in daily routines. Both situations can activate neuroendocrine and immune processes, but they present distinct hypotheses about adaptation, recovery, and the accumulation of exposure.

The controlled viral-challenge literature illustrates how subjective measures can be tested against objectively defined health outcomes. Cohen, S., Tyrrell, D. A. J., & Smith, A. P (1993) examined life events, perceived stress, negative affect, and prospectively documented clinical illness after viral administration. Their findings established associations across several stress-related measures in a constrained experimental exposure context. However, associations among psychological scales also raise questions about common method variance and overlapping constructs. The fact that multiple measures predict an outcome does not show that each captures a distinct biological pathway.

Individual differences may moderate the consequences of exposure through appraisal, coping, social resources, sleep, and physiology, while those same variables can become confounders if their temporal roles are not specified. An investigator seeking a total stress effect should not automatically adjust away behaviors that may mediate it. An investigator seeking direct neuroimmune mediation needs more extensive causal assumptions, repeated measures, and sufficiently precise biomarkers.

This dossier accordingly treats stress appraisal as one component in a multi-stage causal structure. Psychological meaning matters because central and peripheral systems respond to conditions as processed by an organism; disease susceptibility still depends on immune biology, pathogen properties, host history, and social conditions beyond appraisal.

Temporal Architecture of Acute and Chronic Stress

The duration and sequence of stressors are decisive because different components of immunity operate on different time scales. Acute sympathetic activation can rapidly redistribute leukocyte populations and change innate responsiveness. Repeated or persistent adversity may be associated with changes in inflammatory signaling, sensitivity to glucocorticoid feedback, and immune function assessed over weeks or months. Biological phases must be separated: activation, trafficking, pathogen encounter, tissue injury, resolution, and adaptation can have opposite implications for measured markers.

The meta-analysis by Segerstrom, S. C., & Miller, G. E (2004) found that acute stressors were linked with potentially adaptive elevations in selected natural immune parameters and decreases in selected specific immune functions; brief naturalistic stressors showed another pattern; chronic stressors were associated with suppression across several cellular and humoral measures. These patterns summarize heterogeneous research and should not be used as a deterministic individual rule. Assays, host characteristics, and context remain important.

Dhabhar, F. S (2014) further emphasized functional distinctions between short-term stress responses that may support surveillance and prolonged responses that may undermine regulation. The word adaptive refers to a hypothesis about function and evolutionary context, not a guarantee that every acute stressor improves immunity. Likewise, observing an elevated inflammatory cytokine after an acute challenge does not itself establish harm.

Temporal precision matters particularly for inflammatory measurements. Steptoe, A., Hamer, M., & Chida, Y (2007) reviewed changes in circulating inflammatory factors after acute psychological stress, while Marsland, A. L., Walsh, C., Lockwood, K., & John-Henderson (2017) integrated evidence from circulating and stimulated inflammatory outcomes. Immediate post-task sampling, delayed cytokine responses, and baseline chronic levels answer distinct questions. A single time point can miss a delayed change or mistake ordinary circadian variation for stress reactivity.

For disease susceptibility, the time scale must fit the endpoint. The probability of a cold after controlled virus exposure is observed over days; antibody response to vaccination is followed across a longer immunological interval; wound repair involves a sequence of hemostasis, inflammation, proliferation, and remodeling; chronic cardiometabolic disease develops over years. The strongest explanation joins psychological history, measured biology, and disease timing without collapsing them into a general notion of bodily stress.

Sympathetic and Neuroendocrine Signal Pathways

Psychological stress reaches immune tissues through pathways that maintain physiological coordination across threatening and demanding circumstances. Sympathetic nerves release noradrenaline locally, while adrenal medullary activity increases circulating catecholamines. The hypothalamic–pituitary–adrenal axis changes glucocorticoid signaling over a different temporal profile. These systems influence leukocyte movement, the availability of immune cells at tissue sites, cytokine production, metabolic resource allocation, and the transcriptional programs through which cells respond to changing conditions. Their effects vary with receptor distribution, tissue location, phase of the immune response, and the history of exposure.

A mechanistic analysis must distinguish the psychological initiating condition from the signaling processes through which it can act. Social-evaluative threat can alter autonomic arousal in a laboratory challenge, while persistent caregiving demands may repeatedly engage multiple physiological systems over months. Sympathetic activation is often measured indirectly through heart rate, blood pressure, or circulating catecholamines. Such indices indicate aspects of autonomic activity without specifying the activation state of every immune organ. Likewise, cortisol measurements describe one aspect of endocrine activity, not a comprehensive account of hypothalamic, pituitary, adrenal, and receptor-level regulation.

Irwin, M. R., & Cole, S. W (2011) organized reciprocal neural–immune regulation around the capacity of the brain to alter innate immune inflammatory activity and of inflammatory processes to signal back to neural circuits. An important implication is that immune regulation can be anatomically distributed. A rise in circulating cells can reflect redistribution from a marginated pool rather than greater total cellular production. A change in peripheral blood transcription can reflect a shift in cell types, different activation within the same cells, or both. These explanations require distinct measurements and cannot be resolved by a single summary biomarker.

The time course of neural and endocrine signaling helps explain why acute stress and chronic stress are empirically different exposures. A rapid response may direct surveillance cells toward compartments likely to encounter injury, whereas recurrent exposure may change receptor sensitivity and regulatory feedback. Dhabhar, F. S (2014) treats short-term stress as potentially mobilizing selected defense functions, while prolonged activation may undermine appropriate immune coordination. This is a conditional physiological account. Its clinical meaning depends on pathogen, host, tissue, and the specific disease endpoint.

The neighboring dossier on Stress Neurobiology and Hypothalamic–Pituitary–Adrenal Regulation develops detailed neural and endocrine regulation in its own right. The present study uses those mechanisms where they are needed to explain immunological outcomes: altered response to infection, disturbed repair, inflammatory signaling, and functional antibody production. For each pathway, the evidentiary question remains whether a documented signal mediates the association between measured stress and measurable disease rather than merely accompanying it.

Glucocorticoid Sensitivity and Inflammatory Control

Glucocorticoids normally help regulate immune responses, including the magnitude and resolution of inflammation. A persistent stress exposure can alter both the hormone signal and how immune cells respond to it. The concept of glucocorticoid receptor resistance describes reduced cellular responsiveness to glucocorticoid-mediated regulation under specified experimental conditions. This construct concerns receptor and downstream functional sensitivity and should be distinguished from a simple observation of high or low blood cortisol.

Miller, G. E., Cohen, S., & Ritchey, A. K (2002) developed a glucocorticoid-resistance model to explain why chronic psychological stress could coexist with heightened proinflammatory cytokine signaling even though glucocorticoids often act as regulators of inflammation. The study and framework shifted attention from hormone concentration to tissue responsiveness. Reduced sensitivity offers a plausible route through which prolonged stress could impair negative feedback on inflammatory activity while leaving other immune functions altered in different directions.

The controlled infection studies of Cohen, S., Janicki-Deverts, D., Doyle, W. J., Miller, G. E (2012) tested related ideas with prospective stress measures, glucocorticoid sensitivity, and subsequent experimentally assessed respiratory illness. The distinctive value of that work lies in linking a putative cellular mechanism to a clinical endpoint under controlled viral exposure. Its interpretation still depends on whether the chosen assay accurately captures the relevant regulatory pathway and how well the study handles alternative influences including sleep, preexisting host immunity, smoking, and exposure history.

Glucocorticoid resistance is a family of operational findings, not a universally stable trait. Different cell populations, ligands, stimulation protocols, concentrations, and readout times can produce different estimates. An in-vitro assay of suppression of cytokine production offers useful information about cellular responsiveness under its conditions; it does not measure every in-vivo effect of cortisol. Studies that label a single cytokine response as general resistance risk overstating mechanistic specificity.

The pathway is consequential for infection because an appropriately timed inflammatory reaction can help contain pathogens, while excessive or poorly resolved inflammation may contribute to symptoms and tissue damage. Susceptibility and severity therefore require separate outcomes. A person may become infected at one rate yet develop clinical signs of a different intensity, and the neuroimmune mechanisms governing these transitions need not be identical. The mechanistic claim is strongest when stress precedes altered regulation and both precede a defined infection-related outcome, with repeated sampling that fits the proposed sequence.

Immune Cell Trafficking and Tissue-Specific Effects

Immune cell counts measured in a venous blood sample represent a snapshot of a system whose cells continuously migrate among blood, lymphatic tissues, marrow, and peripheral organs. Acute changes after a stressor may arise from redistribution, adhesion changes, or altered egress, rather than newly generated leukocytes. The anatomical location of a cell matters for its capacity to detect antigens, mediate inflammation, and support tissue repair. A higher circulating natural killer cell count is therefore insufficient evidence that the organism has become globally more resistant to infection.

Acute stress experiments have often measured lymphocyte subsets, natural killer cell activity, cytokine changes, and antibody-related responses. These endpoints occur on different timescales and address different immune functions. Segerstrom, S. C., & Miller, G. E (2004) found meaningful variation across immune domains and stressor types in their extensive meta-analysis. The results argue for prespecifying an outcome family based on a mechanistic hypothesis rather than measuring many available markers and selecting a convenient pattern after the fact.

Tissue-level measurement becomes especially important during wound repair. Skin injury initiates an orchestrated response involving hemostasis, immune-cell recruitment, inflammatory signaling, tissue rebuilding, and remodeling. Local inflammatory signals are necessary for repair, yet excessive or prolonged activation can interfere with normal progress. A study using standardized wounds examines the integrated performance of these processes and can therefore address a functional consequence more directly than an isolated plasma cytokine value.

Kiecolt-Glaser and colleagues (1995)92899-5) observed slower closure of standardized skin wounds among older adults under prolonged caregiving stress compared with matched controls. The finding provides evidence for a relation between chronic psychological context and tissue repair, but the sample was small and participants were not randomly assigned to life circumstances. The causal interpretation is consequently narrower than the mechanistic relevance: it shows a meaningful physiological endpoint associated with a naturalistic stress exposure under a common assessment protocol.

Gouin, J.-P., & Kiecolt-Glaser, J. K (2011) reviewed the measurement techniques and mechanisms used in the stress-and-healing literature, emphasizing that repair must be measured directly and longitudinally. Clinical extrapolation requires attention to injury type, infection, metabolic conditions, medications, wound care, and comorbid disease. Experimental wound models can illuminate specific pathways without predicting the course of every surgical wound or chronic ulcer.

Inflammatory Cytokines and Sickness Behavior

Inflammatory cytokines act as signaling molecules within immune responses and as inputs to neural regulation. They influence the recruitment and activation of cells and participate in the coordination of defense and repair. Their functions are contextual: an inflammatory signal necessary during acute infection can become harmful when excessive, prolonged, or situated in the wrong tissue. Thus the statement that psychological stress is associated with higher inflammation requires specification of the molecule, sampling context, baseline condition, and relevant health outcome.

Acute laboratory-stressor studies produce time-dependent changes in selected circulating inflammatory markers. Steptoe, A., Hamer, M., & Chida, Y (2007) combined available studies of circulating inflammatory factors and considered methodological sources of variation. Marsland, A. L., Walsh, C., Lockwood, K., & John-Henderson (2017) later reviewed circulating and stimulated inflammatory outcomes with more differentiated assessment. Their synthesis demonstrates both the reproducibility of certain stress-related inflammatory responses and the difficulty of comparing studies with dissimilar tasks, assays, and sampling times.

A plasma cytokine measurement is influenced by biological rhythms, infection, recent activity, adiposity, medication, and technical assay features. Measures drawn immediately after the challenge may miss a response that develops later. Statistical adjustment can reduce some confounding, yet decisions about which variables to adjust must follow a causal model. If sleep disruption is part of the pathway from chronic stress to inflammation, treating it as a confounder can obscure a total effect. If infection preceded stress measurement, pathogen-driven cytokine activity can distort the inferred direction of influence.

Immune-to-brain signaling adds an interpretive complication. Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W (2008) described sickness behavior as an organized constellation of altered activity, fatigue, appetite, motivation, and social engagement during inflammatory activation. These changes can support recovery under some circumstances and overlap phenomenologically with aspects of depression during others. The overlap is not sufficient to diagnose depression from an inflammatory profile or to infer that a particular person's mood symptoms originate in immune activation.

The reciprocal model predicts feedback: social and environmental conditions can influence inflammatory signaling, and inflammatory signaling can influence behavior, which in turn changes social interactions, sleep, and activity. Prospective designs with repeated immune and symptom measures are required to estimate these directions. A single cross-sectional association between inflammatory markers and distress is compatible with several mechanisms. Translational progress depends on separating them instead of adopting the most intuitive causal narrative.

Transcriptional Responses to Social Adversity

The development of social genomics introduced tools for examining the pattern of gene expression in immune-related cells following social experience. The relevant question is whether chronic social threat, isolation, or adversity is associated with coordinated transcriptional responses that could influence inflammatory and antiviral functions. This approach examines regulation of gene expression in specific cellular material; it does not imply that psychological experiences immediately change the inherited DNA sequence.

Cole, S. W (2014) synthesized work on the conserved transcriptional response to adversity, often discussed as a pattern involving increased transcription of some proinflammatory genes and decreased transcription of selected antiviral or antibody-related genes. The framework offers a more differentiated account than overall immunosuppression. Its explanatory appeal comes from identifying potentially distinct defensive trade-offs under recurring social threat.

The measurement problem is substantial. Blood samples contain shifting mixtures of neutrophils, monocytes, lymphocytes, and other cells with different baseline gene-expression profiles. A difference in a composite expression signature might reflect cell-composition change rather than within-cell regulatory change. Studies therefore need to consider cellular deconvolution, direct subset measurement, sample processing, batch effects, multiplicity, and appropriate validation datasets. Such controls are essential before using expression patterns to argue that a particular social condition caused a particular immune state.

Most human social-genomic studies are observational or involve short interventions measured against transcriptomic endpoints. Their findings are valuable for generating mechanistic hypotheses, but genetic expression signatures are not interchangeable with later disease incidence. A biologically coherent gene set may help direct research toward inflammatory and antiviral pathways while requiring independent demonstration of clinical significance and causal mediation.

The genomic perspective has also expanded the unit of analysis. A social environment can alter exposure to pathogens, access to care, work schedules, sleep, nutrition, and psychological appraisal. A complete account must therefore consider the possibility that gene-expression differences reflect multiple, interacting environmental pathways. The aim is to identify which pathways can be manipulated and which changes persist, rather than to assign all variation to subjective states.

Sleep, Social Behavior, and Behavioral Mediation

Behavior is a central mechanism in stress-related disease susceptibility because daily activities change both immune regulation and pathogen exposure. Sleep continuity and duration, smoking, physical activity, diet, social contact, and treatment behavior can vary with psychological stress. These factors may function as mediators of stress effects, independent causes of health outcomes, or confounders, depending on their measured temporal relation to the exposure. Their classification must be established by a causal research design.

Prather, A. A., Janicki-Deverts, D., Hall, M. H., & Cohen, S (2015) combined behaviorally assessed sleep duration with a controlled respiratory-virus challenge. Sleep was measured before exposure, providing a stronger temporal sequence than studies asking ill participants to recall usual sleep afterward. The study found that shorter habitual sleep was associated with increased likelihood of a clinically defined cold under controlled exposure conditions. Sleep duration itself was not randomized, however, so behavioral and biological explanations remain open and confounding cannot be fully ruled out.

Social behavior also carries multiple pathways. A wide network may offer emotional and practical support, reduce perceived threat, and encourage healthier routines; it may simultaneously increase contacts with other people and possible pathogen exposure. A properly designed infection study must distinguish these pathways. Cohen, S., Doyle, W. J., Skoner, D. P., Rabin, B. S., & Gwal (1997) tested the association between social ties and subsequent cold outcomes using experimentally controlled exposure, suggesting that measures of social integration may carry information beyond simple contact frequency. That evidence remains population- and protocol-specific.

The relationship between stress and health behavior is neither automatically linear nor uniformly adverse. Some acute demands interrupt sleep, while others lead to compensatory rest or changed activity. Prolonged stress may disrupt consistent routines, and constrained environments may make recommended behaviors difficult regardless of motivation. The scientific task is to locate behavioral changes in the temporal process linking exposure and disease, accounting for resource differences and alternative causes.

A mechanistic intervention could in principle change sleep regularity, reduce stress appraisal, improve social support, or alter immune signaling. To establish mediation, studies would need to show that the intervention changes the proposed mediator before the immune or clinical outcome, estimate uncertainty, and test plausible alternative pathways. Improvement in self-reported stress plus a changed immune marker is suggestive but does not independently prove that a particular behavioral route produced the change.

Biological Embedding of Early Adversity

Early adversity has been investigated as a possible contributor to long-term changes in stress responsivity, inflammatory regulation, health behavior, and disease vulnerability. The relevant exposures include deprivation, threat, family stress, insecure social conditions, and other experiences that differ in severity, duration, and developmental timing. Life-course analysis asks how early environments interact with later social circumstances and biological development, rather than attributing adult disease to a single remembered event.

Miller, G. E., Chen, E., & Parker, K. J (2011) developed a broad model of pathways connecting childhood psychological stress with later chronic disease risk. The synthesis considered behavioral, inflammatory, neuroendocrine, and developmental routes by which early exposure might acquire long-term effects. The framework is mechanistically informative, while the evidence base includes many observational studies that are vulnerable to confounding by family resources, inherited traits, environmental exposures, and subsequent life conditions.

Nusslock, R., & Miller, G. E (2016) described a neuroimmune network hypothesis linking early adversity to emotional and physical health across the lifespan. Their model emphasizes reciprocal effects among neural threat-processing systems, peripheral immune responses, and behavior. It provides hypotheses about developmental calibration and sustained inflammatory regulation, which can be examined using repeated measurements, natural experiments, and intervention designs.

Telomere studies have often been invoked as examples of biological embedding. Epel, E. S., Blackburn, E. H., Lin, J., Dhabhar, F. S., Adle (2004) reported associations between perceived or chronic life stress and telomere-related measures in a specific sample. Such findings should be interpreted as exploratory evidence for possible links between stress history and cellular-aging indicators. Telomere length is affected by age, immune-cell composition, assay method, and many exposures; it is not a precise personal timer of stress damage or a substitute for measuring clinical disease.

Developmental inference requires explicit attention to selection and shared causes. Children experience stress in families and institutions that also shape nutrition, infection, environmental toxin exposure, medical access, and education. Adult retrospective reports can introduce recall error, while longitudinal birth cohorts offer temporal advantages but remain observational. Natural experiments, within-family designs, repeated immune measurements, and appropriately controlled interventions can each address parts of this problem, yet no single design eliminates every ambiguity.

A responsible synthesis recognizes two compatible conclusions. Persistent adversity can plausibly participate in enduring physiological and behavioral pathways, and the degree of causal attribution for a specific disease remains dependent on the available design and endpoint. The purpose of this dossier is to identify these pathways and their evidentiary status, preserving human adaptability and variation rather than converting life history into a deterministic medical prognosis.

Controlled Viral Challenge as a Test of Disease Susceptibility

Human viral-challenge experiments provide an unusually informative design for studying how preexisting psychological characteristics predict infection outcomes because the timing and nature of pathogen exposure are specified by the researchers. The study of Cohen, S., Tyrrell, D. A. J., & Smith, A. P (1991) assessed psychological stress before participants received a controlled administration of respiratory viruses or a saline control. The investigators distinguished evidence of infection from clinical cold symptoms and examined whether stress measures predicted outcomes after exposure. The design addresses an important source of ambiguity in community epidemiology: people experiencing stress might simply encounter infectious contacts at different rates.

The original report involved 394 healthy volunteers assigned to one of several viral exposure conditions and 26 receiving saline, with procedures designed to observe subsequent infection and illness. Within the controlled exposure group, higher psychological stress was associated with greater susceptibility. This association was observed despite the fact that pathogen administration was organized by the study, supporting the possibility of host-level vulnerability rather than only increased opportunities for exposure. It did not establish that stress was randomized or that psychological stress alone caused illness in every individual. Existing immunity, behavioral characteristics, and unmeasured biological differences remained potential influences.

The trial illustrates why the definition of an outcome matters. Infection can be identified through viral isolation or a specific immune response, while clinical illness typically requires signs or symptoms in addition to infection. Symptoms may vary because of viral replication, host inflammatory response, and symptom perception. Investigators should therefore distinguish infection acquisition, clinically significant illness, symptom burden, and their duration. A psychological variable might relate to one transition in this sequence more strongly than another.

Cohen, S., Tyrrell, D. A. J., & Smith, A. P (1993) considered negative life events, perceived stress, negative affect, and related predictors of common-cold susceptibility. The work reinforced the value of measuring psychological exposure before infection, while highlighting overlap among stress-related constructs. Perceived distress, exposure to events, and emotional disposition can correlate for conceptual and measurement reasons; their predictive value must be examined with careful models.

The distinctive strengths of controlled viral challenge are temporal ordering, standardized monitoring, and a clinical outcome following known exposure. Its limitations include selected volunteers, restricted pathogens, carefully monitored environments, and ethical constraints. A response to a mild experimental respiratory infection should not be extrapolated directly to severe infectious diseases or population-level mortality. Still, the design establishes an empirical bridge between psychosocial conditions and clinically meaningful host responses that many marker-only studies cannot provide.

Chronic Stress, Stressor Type, and Duration

The category of psychological stress contains heterogeneous experiences, and chronicity is only one dimension. Stressors also differ in social content, predictability, perceived control, severity, and the availability of coping resources. A few demanding days may elicit changes in autonomic arousal and leukocyte distribution, while a prolonged role conflict may involve disrupted sleep, repeated vigilance, and altered regulation across several endocrine and immune systems. The challenge for infection research is to identify which dimensions prospectively predict relevant outcomes.

Cohen, S., Frank, E., Doyle, W. J., Skoner, D. P., Rabin, B (1998) investigated the types of stressors associated with increased common-cold susceptibility in healthy adults. Their work specifically addressed duration and stressor characteristics within the viral-challenge research program. The results supported the importance of persistent stressors rather than treating a simple life-event count as a sufficient representation of vulnerability. The study encourages models that distinguish exposure duration from emotional response.

A sustained social or economic stressor can be associated with multiple explanatory pathways. A person's living conditions may influence sleep opportunity, nutrition, physical activity, environmental exposures, and access to care at the same time that they influence threat appraisal. Statistical control for these variables may be useful when estimating a particular direct effect but can remove causal mediation when estimating the total burden of sustained adversity. Investigators need explicit diagrams and temporal hypotheses to decide what adjustment means.

The larger evidence review by Segerstrom, S. C., & Miller, G. E (2004) offered a complementary perspective. By comparing different stressor classes and immune assays across studies, it showed that acute stress cannot simply be assigned the same immunological pattern as chronic stress. This synthesis supplies conceptual context for the viral-challenge findings, but immune-assay associations across heterogeneous studies do not automatically replicate a measured infection risk.

Stressor heterogeneity also complicates intervention design. An intervention that reduces subjective distress might leave exposure to unsafe working conditions unchanged; a structural intervention that reduces demands might alter biological and behavioral pathways without producing a large shift on a short questionnaire. The clinically meaningful question is which aspects of stress exposure contribute causally to a defined disease outcome in a particular population.

Social Ties, Integration, and Host Resistance

Social relationships can shape immune-relevant pathways through companionship, support, behavioral regulation, shared resources, and the psychological meaning of belonging or isolation. Yet social interaction also changes contact patterns and potential pathogen exposure. Any claim that social integration alters susceptibility must account for the possibility that more social contact increases exposure while psychosocial resources change responses after exposure.

Cohen, S., Doyle, W. J., Skoner, D. P., Rabin, B. S., & Gwal (1997) examined social ties and susceptibility to experimentally administered respiratory viruses. The study offered evidence that the breadth of social ties predicted clinical cold outcomes in the controlled-exposure setting. Its interpretive strength is the effort to standardize inoculation and assess illness prospectively. It does not establish that deliberately increasing the number of social roles would reduce an individual's infection probability by the same amount.

Social integration, social support, loneliness, and interpersonal conflict are distinct constructs. Integration concerns relationships and roles; support concerns available or received assistance; loneliness concerns a perceived discrepancy between desired and actual connection; conflict concerns threatening or demanding interactions. A person may have many social contacts but experience high loneliness, or have a small network that is emotionally secure. Measures that collapse these dimensions make mechanistic explanation difficult.

The reciprocal nature of the relationship also matters. Illness can reduce social participation and change how others respond, creating a path from biological status to social circumstances. Repeated illness might alter work, financial stability, and subjective isolation, all of which may then shape future stress exposure. Prospective methods with careful baseline health assessment offer stronger separation of these alternatives than a cross-sectional survey.

Human–Artificial relations in the Artificial Era may eventually affect perceived social support and stress appraisal, but an artificial partner's conversational responsiveness is not in itself evidence of improved immune protection. Research would have to test whether such interactions change established mediators and objectively specified clinical outcomes in randomized or appropriately controlled studies. The scientific principle remains the same across human and digitally mediated relationships: interpersonal meaning and biological consequence are separately measured propositions.

Glucocorticoid Regulation in Experimental Respiratory Illness

A major advance beyond broad stress-illness associations is the specification of a candidate physiological mediator. Chronic stress has been hypothesized to make certain immune cells less responsive to glucocorticoid regulation, thereby permitting excessive or poorly coordinated inflammatory responses. This hypothesis is important because inflammatory activity can contribute to the clinical expression of respiratory infection even while serving protective functions.

Cohen, S., Janicki-Deverts, D., Doyle, W. J., Miller, G. E (2012) investigated chronic stress, glucocorticoid receptor resistance, and disease risk using controlled viral-challenge data and related experimental assessments. Their analyses connected psychosocial exposure, an immunoregulatory function, and an illness endpoint. Because stress was not randomized, the findings support a biologically specific mediational account without delivering definitive proof that manipulating receptor resistance would prevent colds.

Glucocorticoid receptor resistance can be studied in immune cells under laboratory conditions, often by examining the extent to which glucocorticoids suppress stimulated cytokine production. Such assays are closer to cellular function than a static cortisol concentration. They nevertheless simplify conditions encountered within living tissues and are affected by sample handling, cell composition, and stimulation protocol. Replication across independent studies, immune compartments, and assay choices is required to determine generalizability.

Inflammation is not an unqualified sign of immune failure. During a respiratory infection, inflammatory responses are central to defense and also contribute to symptoms. An altered regulatory response could lead to greater symptomatic illness without necessarily increasing the earliest step of infection establishment. Conversely, inadequate antiviral defense could change viral replication with another inflammatory pattern. The original controlled challenge literature underscores the necessity of retaining infection, symptoms, and immune response as separate measured variables.

Translational hypotheses follow from this research, but they require intervention studies capable of altering the putative pathway and observing an outcome. A biomarker association provides a pathway candidate. Experimental manipulation and temporal mediation testing are needed before receptor sensitivity can be promoted as a proven therapeutic target for stress-related susceptibility.

Sleep Duration and Experimental Infection Outcomes

Sleep is a biologically relevant exposure in its own right and one way stress may influence host defenses. Sleep duration and continuity affect endocrine, autonomic, metabolic, and immune regulation; they also vary with work schedules, family responsibilities, housing conditions, disease, and psychological distress. Studies of stress-related susceptibility should therefore measure sleep rather than automatically treating it as an unobserved background factor.

Prather, A. A., Janicki-Deverts, D., Hall, M. H., & Cohen, S (2015) examined behaviorally assessed sleep and subsequent susceptibility to a common cold after controlled viral exposure. The study recruited healthy adults, monitored sleep prior to inoculation, and assessed subsequent cold development. The prospective use of sleep monitoring reduced reliance on retrospective reports that might be biased by current illness. The work found an association between shorter habitual sleep and a higher probability of developing a clinically defined cold under these conditions.

The sample comprised 164 participants; the authors' main comparisons indicated materially higher odds among those sleeping fewer hours compared with longer-sleeping participants. Any numerical odds ratio must be read together with the reference category, confidence interval, adjusted variables, and the observational nature of sleep exposure. It is not scientifically equivalent to a randomized experiment in which investigators assign sleep schedules for a defined duration.

Sleep may mediate part of the relation between stress and infection, but stress, sleep, and health can also share underlying causes. Chronic illness may disturb sleep before a new exposure is studied. Employment arrangements may constrain sleep while generating reported stress. Host factors may affect both sleep and immune signaling. A rigorous mediation study would need repeated assessments across stress, sleep, immune regulation, and the clinical disease event, with careful temporal design.

Prather and colleagues' research matters because it combines an ecologically meaningful behavioral measure with a controlled infection endpoint. It supports further causal testing of sleep as an explanatory pathway rather than establishing a precise universal sleep prescription from the observed association. The practical significance lies in acknowledging that psychological and biological pathways are inseparable from ordinary daily environments.

Vaccination and Functional Antibody Responses

Vaccination research offers a functional immune endpoint that differs from both circulating inflammatory markers and acute infection after viral inoculation. Antibody responses to a standardized immunization can be measured prospectively after antigen exposure, and their trajectory may provide information about aspects of adaptive immunity. A lower titer at a specific follow-up point does not automatically translate into a measured probability of clinical infection, however, and vaccine-specific protection depends on immune history, antigen, age, and the relevant protective correlates.

Vedhara and colleagues (1999)06098-X) studied chronic stress in older caregivers of people with dementia and their antibody response to influenza vaccination. The design addressed a meaningful naturalistic burden while observing responses to a defined immunological challenge. Findings suggested that chronic caregiving stress can be associated with an altered vaccine response in a selected population. The study also illustrates the difficulty of isolating stress from sleep disruption, coexisting disease, medication use, and other aspects of caregiving.

Kiecolt-Glaser, J. K., Glaser, R., Gravenstein, S., Malarkey (1996) examined chronic caregiving stress and influenza vaccination among older adults, comparing caregivers with age-matched controls. These studies contributed to the early proposition that chronic psychosocial burden can affect specific adaptive immune functions. Nevertheless, antibody response is influenced by prior exposure to influenza strains, vaccine composition, and baseline immune status. Between-person comparisons require adequate baseline measures, follow-up intervals, and recognition of the substantial changes that can occur with aging.

The term vaccine efficacy has a particular clinical meaning derived from disease outcomes in appropriately designed studies. Psychoneuroimmune studies measuring antibody titer generally estimate an immunological response, not vaccine efficacy in preventing diagnosed infection. A change in antibody production may be biologically important and still leave uncertainty about clinical protection. Some vaccine responses rely on cellular immunity or other mechanisms beyond the antibody assay used.

The strongest future designs will combine stress exposure measurement, defined immunization history, repeated functional immune measurements, and—where feasible—subsequent clinically verified outcomes. Randomized supportive interventions could test whether changing a stress-related pathway modifies the measured response. Evidence should be reported by vaccine, host population, and endpoint rather than converted into an unsupported claim that stress universally causes vaccine failure.

Wound Healing and Repair Under Chronic Caregiving Stress

Wound healing is an especially instructive psychoneuroimmune endpoint because it concerns an observable biological process that requires coordination between inflammation and tissue reconstruction. Standardized skin wounds can be monitored repeatedly, and changes in closure time capture the integrated function of multiple cellular processes. Psychological stress could plausibly affect healing through neuroendocrine regulation, local immune signaling, sleep, behavioral care, or combinations of these mechanisms.

The influential study by Kiecolt-Glaser, Marucha, Malarkey, Mercado, and Glaser (1995)92899-5) compared 13 women caring for relatives with dementia with 13 control participants, using a standardized punch-biopsy wound. The investigators reported slower healing in the caregiver group. Their observed mean wound-closure times were approximately 48.7 days for caregivers and 39.3 days for controls. These details are specific to the design and sample; the numbers should not be treated as estimates for all caregivers or all clinical wounds.

The experiment provides a functional measurement more directly relevant to host repair than a broad cytokine screen. However, caregiving status was not randomly assigned, and the small groups could differ on relevant variables that were measured imperfectly or not at all. The study therefore supports a plausible biological relationship under controlled wound creation, while causal attribution to stress alone remains restricted.

Gouin, J.-P., & Kiecolt-Glaser, J. K (2011) reviewed laboratory and mechanistic work on stress and wound healing, emphasizing the phases of tissue repair and possible neuroendocrine and immune pathways. The timing of inflammatory mediators is essential. An early local inflammatory response contributes to normal repair, while excessive or persistent inflammation may interfere with progress. Consequently, suppressing every inflammatory measure cannot be assumed to enhance healing.

Wounds differ by depth, anatomical site, vascular supply, infection status, metabolic condition, medication, and quality of wound care. Extending findings from standardized punch biopsies to surgical recovery or chronic wounds requires additional clinical study. A research monograph can treat the association as significant evidence for organism-level stress physiology while preserving these constraints on generalization.

Integrated Interpretation of Infection and Repair Evidence

Controlled viral exposure, vaccination-response studies, and standardized wound healing are methodologically complementary, but their endpoints cannot be pooled as a single undifferentiated measure of immunity. Viral challenge observes host response after known pathogen exposure. Vaccination studies measure aspects of an acquired antigen-specific response over time. Wound-healing studies assess coordinated inflammation and tissue reconstruction. These functions may respond differently to acute and chronic stress.

The research designs also locate sources of causal strength at different stages. Randomization or standardization of antigen or wound exposure helps control an important biological condition; it does not randomize the participant's chronic stress history. Laboratory stress tasks can randomize a psychological challenge but often observe immune biomarkers rather than clinically verified disease. Intervention trials can randomize a stress-reduction program but may have multiple active ingredients and incomplete participant masking. Combining these study types improves triangulation without erasing their distinct limitations.

A causal diagram for stress-related infection might include chronic adversity, psychological appraisal, sleep, neuroendocrine signaling, immune-cell responsiveness, prior immunity, pathogen exposure, viral replication, inflammatory symptoms, and healthcare behavior. Variables such as age, medications, chronic conditions, smoking, socioeconomic position, and prior infections can influence several pathways at once. The relevant confounders depend on the specific exposure and endpoint; they cannot be selected through a universal checklist.

The literature's most secure general conclusion is that psychological and social circumstances can be associated with—and in certain experimental contexts can influence—measurable immune processes. Controlled human challenge research supports stress-related differences in susceptibility to some respiratory infections under specific conditions. Functional tissue-repair studies and immunization experiments widen the range of plausible outcomes. Research on severe infections, broad chronic-disease incidence, or general immune enhancement requires its own endpoints, designs, and replication.

The synthesis therefore preserves an empirical hierarchy: demonstrated signaling pathways support mechanistic plausibility; well-controlled biomarker and physiological studies show measurable regulation; prospective clinical studies connect exposures with disease; and randomized interventions capable of changing clinical endpoints would provide stronger evidence for prevention. Claims made at one level should remain identified with that level.

Disease Endpoints and the Surrogate Marker Problem

The interpretation of psychoneuroimmune findings depends fundamentally on the endpoint. The term disease susceptibility may refer to the probability of becoming infected following a specified exposure, the probability of symptomatic illness among infected individuals, the risk of a chronic disease diagnosis over an interval, or a measurable deficit in tissue repair. Each outcome has a different causal structure. None can be replaced without argument by a general laboratory indicator labeled immune function.

Circulating inflammatory markers such as C-reactive protein and interleukin-6 can be useful measures of inflammatory state or response, but they can change for many reasons. Their concentration at a selected time does not uniquely identify the causal pathway or the clinical consequence. Cellular responses measured after ex-vivo stimulation, lymphocyte proliferation, natural killer activity, antibody titers, gene-expression signatures, and wound-closure times are also biologically different outcomes. A research design that includes several such measures must specify which are primary, what direction of change is hypothesized, and how multiplicity will be controlled.

The functional outcomes examined by Cohen, S., Tyrrell, D. A. J., & Smith, A. P (1991) and by Kiecolt-Glaser and colleagues (1995)92899-5) are particularly valuable because they connect psychosocial context with documented infection or tissue repair. Yet even these outcomes are bounded: a challenge-virus cold and a standardized biopsy wound do not represent every possible infection or injury. Their strength lies in observable processes under specified conditions, not in universal representation.

The meta-analysis of randomized psychotherapeutic or psychosocial interventions by Shields, G. S., Spahr, C. M., & Slavich, G. M (2020) demonstrates why outcome-level clarity matters. It documents changes in measured immune function across trials, but the pooled immune effect is not a pooled reduction in clinically diagnosed disease. A reader seeking evidence that stress reduction prevents a particular infection, autoimmune disorder, or malignant disease must evaluate dedicated clinical outcomes, not extrapolate from changes in immune biomarkers alone.

Surrogate endpoints can support a disease mechanism when their causal relation to clinical outcomes has been independently established and validated in the intended context. Without such validation, a statistically significant marker shift is evidence about the marker. The monograph accordingly evaluates each study at its observed level, recognizing mechanistic coherence while maintaining a clear threshold for clinical susceptibility claims.

Immune Measurement, Assay Validity, and Sampling Time

Psychoneuroimmune experiments use diverse assays to characterize innate and adaptive responses. Measures include complete leukocyte counts with differential, functional lymphocyte and natural killer assays, antigen-stimulated cytokine production, circulating soluble mediators, antibody responses after immunization, and molecular transcription profiles. Each assay has a distinct measurement target and uncertainty. Laboratory instruments are therefore part of the scientific model, rather than neutral windows into a singular immune strength.

For cytokines, preanalytical and analytical conditions can influence results. Collection time, sample matrix, processing interval, freezing and thawing, detection limit, assay platform, and inflammatory conditions in the participant can all matter. Studies need to document these features so that between-group differences are interpretable and replicable. A small post-stressor cytokine signal near an assay's detection threshold deserves a different evidentiary assessment from a well-replicated change across several independent protocols.

Timing is a persistent challenge. A laboratory stressor may evoke rapid autonomic effects, followed by later changes in cytokine concentrations and still later shifts in behavioral symptoms. Steptoe, A., Hamer, M., & Chida, Y (2007) reviewed acute stress-related inflammatory changes, while Marsland, A. L., Walsh, C., Lockwood, K., & John-Henderson (2017) broadened the synthesis to circulating and stimulated outcomes. The results depend partly on when samples were collected. Time-series protocols and prespecified sampling schedules are preferable when the mechanistic hypothesis predicts delayed effects.

Cell composition complicates whole-blood interpretations. If stress redistributes leukocyte subsets, an apparent genomic or cytokine change in mixed-cell blood may reflect a changing population mixture rather than altered function of a stable population. Adjustment or direct measurement of cell fractions may reduce the ambiguity. The cellular approach described by Cole, S. W (2014) therefore benefits from validation against independently defined cell populations.

Repeated sampling must also account for circadian variation, intercurrent infection, medications, sleep, and activity. If a participant develops an unrecognized illness before a research blood draw, inflammatory markers may shift independently of the proposed stress process. Researchers should define exclusion criteria or incorporate appropriately measured illness status. Multi-marker panels increase discovery potential, but also increase the risk of selective reporting unless their use and statistical strategy are transparently specified.

Measurement of Stress and Psychosocial Context

A robust study defines the psychological exposure before choosing a biological assay. Perceived stress scales measure subjective demands and available coping resources over a stated interval. Life-event checklists measure reported event exposures with variable assumptions about severity and duration. Caregiving studies identify a social role but may combine very different hours, responsibilities, financial strains, and emotional relationships. Laboratory evaluative-threat tasks induce a standardized challenge for a short period. These constructs are scientifically related but require distinct interpretations.

Psychological measurement is vulnerable to recall bias, mood-congruent reporting, differential interpretation of questionnaire items, and changes in language or cultural context. A person with current illness may report greater stress because illness itself changes sleep, activity, and perceived coping. Prospective measurement before biological or clinical endpoints reduces some reverse-causation risk, yet does not eliminate shared environmental influences.

Objective exposure measures can add information: work schedules, periods of unemployment, care hours, documented environmental events, and daily time-use records may complement subjective appraisal. Ecological momentary assessment captures stress experiences close to their occurrence and permits examination of daily within-person variation. However, frequent sampling changes participant burden and may itself alter awareness or behavior. Mixed-method research can clarify the meanings assigned to stressful circumstances that fixed instruments sometimes miss.

Cohen, S., Tyrrell, D. A. J., & Smith, A. P (1993) used several psychological exposure measures before viral inoculation, illustrating the opportunity to compare predictive constructs. The interpretive difficulty is that negative affect, perceived stress, and life events are correlated. Factor analysis, discriminant validity testing, and independent replication can distinguish broad common distress from genuinely separate pathways, although they cannot by themselves establish causal relations.

A measurement program should report reliability, construct validity, the time window covered, and sensitivity to change. Comparisons among demographic or cultural groups require evidence that questionnaire items have comparable meanings. The field also benefits from reporting socioeconomic, environmental, and institutional stressors explicitly, rather than interpreting every physiological difference as a consequence of internal psychological disposition.

Experimental Paradigms and Human Challenge Ethics

Different experiments isolate different segments of the proposed causal chain. Animal conditioning experiments manipulate pairings between cues and pharmacological immune agents. Human laboratory challenges manipulate the immediate psychological task and measure physiological changes. Viral inoculation experiments standardize pathogen exposure after naturally varying psychological characteristics are assessed. Psychosocial intervention trials randomize a program and observe outcomes after treatment. Each supports a different causal inference.

The key distinction in the controlled viral-challenge studies is that the virus is experimentally administered while the chronic stress exposure generally is not assigned. Standardized inoculation strengthens inference about differences in host response after exposure; it does not remove possible confounding in the naturally occurring stress groups. Similarly, a randomized laboratory stress task can support causality for short-term immune responses, but it does not automatically demonstrate altered disease incidence.

Human challenge protocols present particular ethical responsibilities. Volunteers must be selected and informed appropriately, pathogen and safety procedures must be strictly managed, and risks monitored with clinical oversight. The research value is high because exposure is known, but the resulting evidence is conditioned by healthy volunteer selection, selected strains, and the protective conditions of study protocols. These features restrict extrapolation to vulnerable populations and severe diseases.

Standardized wound experiments raise related issues about the invasiveness of the tissue procedure, infection prevention, and follow-up. The wound-healing study by Kiecolt-Glaser and colleagues (1995)92899-5) illustrates how an experimentally standardized outcome can be investigated alongside naturalistic social exposure. An ethically justified procedure can create a useful common biological endpoint, while the naturally varying exposure remains observational.

These designs should be interpreted together through a triangulation framework: laboratory manipulation tests immediate physiological response; viral challenge tests susceptibility under known exposure; prospective cohorts estimate longer-term disease associations; randomized interventions test whether changing a program can change immune or clinical outcomes. Convergence strengthens a biological explanation when the endpoints and pathways are compatible. Apparent disagreement may reflect different biological phases rather than a failed replication.

Confounding, Mediation, and Causal Interpretation

Causal inference begins by stating the exposure, outcome, target population, and time interval. A plausible causal structure for stress-related infection includes stressor exposure, psychological appraisal, autonomic and glucocorticoid signaling, changes in immune regulation, prior pathogen immunity, sleep, smoking, social contact, and clinical illness. Common causes such as socioeconomic conditions, chronic disease, medication, age, and occupational environment can affect several of these variables simultaneously.

Distinguishing a confounder from a mediator is essential. Sleep disturbance could mediate the effect of chronic stress on immune function. If investigators adjust for sleep while estimating the total stress effect, they may remove part of the process they intend to study. Conversely, preexisting sleep problems that precede and influence both reported stress and subsequent illness may require adjustment. Correct classification depends on the temporal structure, which cross-sectional data cannot reliably establish.

Mechanistic mediation is a stronger claim than observing that a stress measure correlates with a cytokine and that the same cytokine correlates with illness. It requires appropriately ordered observations, assumptions about unmeasured confounding, sufficient measurement precision, and models consistent with the biological process. Repeated measures, experimental manipulation of candidate pathways, and sensitivity analyses help evaluate competing explanations. Conventional statistical mediation estimates can be misleading when measured variables are influenced by prior outcomes or share unobserved causes.

The study of Cohen, S., Janicki-Deverts, D., Doyle, W. J., Miller, G. E (2012) provides an instructive model because it links chronic stress, glucocorticoid resistance, and experimental cold outcomes. It is valuable because the proposed mediator is biologically specified. Its mechanistic interpretation nevertheless remains dependent on assay validity, temporal structure, and confounding assumptions. Strong causal language should track the actual intervention and design, not the completeness of an attractive theoretical explanation.

Reverse causation is especially relevant in inflammatory research. Immune activation may produce fatigue and depressive symptoms, which can alter responses to psychological stress questionnaires. Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W (2008) reviewed this immune-to-brain pathway. Observational findings of distress alongside inflammation therefore cannot automatically be described as distress causing inflammation. Multiwave studies with objective illness information are necessary to estimate reciprocal processes.

Individual Differences and Population Heterogeneity

Stress-related immune outcomes vary across age, immune history, comorbid disease, sex-related biological processes, medications, and environmental conditions. These differences can affect both biological response and the interpretation of psychosocial exposures. The immune system of a healthy young volunteer responding to an experimentally administered cold virus cannot serve as a universal reference for older adults managing multiple conditions or for children encountering different pathogens and vaccines.

Age is important in studies of vaccine antibody responses and caregiving burdens, while prior immunity influences whether an antigen challenge generates a detectable adaptive response. Inflammatory markers can vary with adiposity, chronic infection, and metabolic conditions. Hormonal states and circadian timing may alter responses, although specific interaction claims require direct analysis rather than broad demographic assumptions. Statistical control may help under a causal model; it cannot manufacture representativeness when sampling excludes important groups.

Socioeconomic and structural settings influence risk through multiple channels. Crowded housing, occupational exposure, access to sick leave, health service availability, neighborhood conditions, and discrimination may affect pathogen exposure, stress burden, and illness outcomes. A stress-only interpretation can conceal direct environmental and institutional causes. A comprehensive study should examine whether measured psychosocial stress adds information beyond these conditions and whether interventions should target the environment rather than only an individual's coping.

Early-life adversity research introduces additional developmental heterogeneity. Miller, G. E., Chen, E., & Parker, K. J (2011) and Nusslock, R., & Miller, G. E (2016) offer theoretical frameworks for long-term neuroimmune development, but the relevant associations should be tested within clearly specified age groups, historical periods, and exposure conditions. Adult inflammatory profiles cannot be assumed to reveal a unique childhood history.

Generalizability is also limited by research geography. Most foundational controlled viral-challenge, caregiving, and intervention studies were conducted in particular institutional and national settings, with selected samples and access to specialized facilities. Replication requires attention to socioeconomic contexts, vaccine schedules, pathogen ecologies, healthcare systems, and cross-cultural measurement equivalence. The research goal is to identify stable mechanisms alongside meaningful boundary conditions.

Systematic Synthesis, Heterogeneity, and Publication Bias

The evidence base includes experiments with small samples, prospective cohorts, observational immune-assay comparisons, laboratory challenge studies, randomized psychosocial interventions, and quantitative syntheses. Each design contributes different information, and meta-analysis can make patterns visible only if the included outcomes and studies are interpreted carefully. A pooled effect across heterogeneous immune endpoints may offer evidence of nonzero average change while leaving its biological meaning unresolved.

Segerstrom, S. C., & Miller, G. E (2004) integrated more than three decades of human stress–immunity research and reported that type and duration of stress are associated with different immunological patterns. This was a major corrective to an overly simple suppression model. Yet publication date, assay technology, case selection, and the shifting research literature affect what such a synthesis can establish for contemporary populations.

The acute stress–inflammation reviews of Steptoe, A., Hamer, M., & Chida, Y (2007) and Marsland, A. L., Walsh, C., Lockwood, K., & John-Henderson (2017) show why assessment method and sampling time should be evaluated alongside pooled statistical outcomes. An early cytokine measurement and a delayed stimulated response may reflect different mechanisms. Combining them without a justified model can produce an apparently precise estimate of an ill-defined construct.

Intervention syntheses introduce additional heterogeneity. Shields, G. S., Spahr, C. M., & Slavich, G. M (2020) identified randomized clinical trials of psychosocial interventions with measured immune endpoints. The strength of random allocation improves causal inference for the intervention's effect on the selected outcome, while differences in intervention content, participant populations, comparator conditions, and laboratory markers complicate claims about a unique psychological mechanism.

Publication bias, selective outcome reporting, incomplete reporting of null findings, and flexibility in analysis are recurring concerns. Immune studies frequently assess many correlated endpoints, which raises the probability of isolated significant results. Preregistration of primary outcomes, reporting of all measured assays, accessible study protocols, transparent statistical models, and independent replication are therefore central to interpreting the literature. Evidence synthesis should consider study quality and heterogeneity before emphasizing a nominally significant pooled estimate.

The present monograph uses critical narrative synthesis rather than a new systematic-review protocol. It draws on original experiments and published systematic reviews to explain the field's structure and limitations. It does not claim comprehensive database screening, registered inclusion criteria, a new risk-of-bias scoring exercise, or a newly computed pooled effect. This methodological boundary is part of its scientific provenance.

Reproducibility and Reporting Standards

Reproducibility in psychoneuroimmunology includes measurement reproducibility, experimental replication, conceptual replication across different operationalizations of stress, and generalization to populations outside a laboratory setting. A change in a cytokine can be reproduced within one assay yet fail to correspond to a consistent clinical outcome. A pathogen-challenge association may be reproduced with similar strains and selected volunteers while behaving differently across age or environmental conditions. These outcomes call for interpretation at the level actually replicated.

Statistical reproducibility requires that investigators report sampling procedures, exclusions, missing observations, analytic models, covariates, effect sizes, confidence intervals, and handling of multiple tests. For neuroendocrine or immune assays, laboratory timing, calibration, specimen handling, batch correction, and biological-state controls should also be documented. A study reporting only a significant marker without its measurement conditions offers limited basis for replication or meta-analysis.

Mechanistic reproducibility requires convergence across levels. If an account proposes that chronic social stress changes glucocorticoid sensitivity and thereby raises illness risk, its strongest evidence would combine prospective stress exposure, repeated receptor-function assays, direct immune processes, and independently documented illness endpoints. Trials that alter a proposed pathway may further test whether changing that mediator changes the downstream outcome. Mechanistic plausibility is most valuable when it generates such discriminating predictions.

External replication should include variation in setting and population. The high-control environment of viral-challenge experiments protects internal inference but can limit ecological validity; community cohorts can capture real-world exposure diversity but face more complex confounding. Multisite coordinated protocols and transparent reporting allow these strengths to be brought into contact.

Research reporting guidelines from the EQUATOR Network and the PRISMA statement are appropriate when a study uses their corresponding design or review methods. The distinction between a narrative monograph and a registered systematic review must remain explicit. Source traceability, accurate bibliographic records, qualification of abstract-only sources, and open documentation of unresolved limitations provide meaningful editorial rigor without claiming a research method that was not actually performed.

Contemporary Neuroimmune Networks and Spatial Biology

Recent neuroimmunological research increasingly examines reciprocal neural–immune interactions as spatially distributed networks rather than as isolated blood-hormone correlations. The review by Wheeler, M. A., & Quintana, F. J (2025) presents the neuroimmune connectome as a framework for studying communication across the central nervous system and peripheral immunity. Its contribution is to integrate anatomical routes, immunological responses, and behavior in a common research program. The review concerns mechanistic organization, and its conclusions about specific disease mechanisms must be evaluated within the relevant clinical or experimental models.

Leunig, A., Gianeselli, M., Russo, S. J., & Swirski, F. K (2025) similarly organize neural–immune communication across sites and timescales. Their published abstract emphasizes interactions in the brain, peripheral organs, and communication across distance, as well as nervous-system influences on immune-cell development, distribution, and function. The perspective suggests that circulating immune markers may incompletely represent processes occurring in lymphoid organs, tissue barriers, and injured sites. That implication is a methodological reason to improve compartment-specific measurement rather than a claim that all relevant mechanisms are already understood.

The anatomical approach is especially relevant for interpreting apparent contradictions in earlier stress literature. A stressor could increase the number of a leukocyte subtype in blood while changing its distribution or function elsewhere. Peripheral cytokine levels could remain stable even as local neuroimmune interactions change at an injured tissue. Single-cell methods, spatial profiling, and more precise neural-circuit assays offer ways to examine these hypotheses, but their clinical value requires validation against functional disease outcomes.

The scientific progression from the early conditioning studies of Ader and Cohen to contemporary connectome models illustrates increasing explanatory resolution. Each new technology addresses an old question: how can an experience processed by the nervous system change immune responses at a remote bodily site? More precise circuit descriptions improve mechanistic specificity; they do not bypass the need to demonstrate which changes materially alter infection, repair, or disease progression in humans.

A particularly instructive original experiment by Poller, W. C., Downey, J., Mooslechner, A. A., Khan, N., Li (2022) combined neural-circuit methods with measurements of leukocyte distribution and functional disease outcomes in mice. The researchers showed that distinct brain circuits could drive different leukocyte trafficking patterns under acute stress, with consequences for the animal models used to examine infection and autoimmunity. The experiment directly demonstrates a pathway linking controlled neural activity to immune-cell behavior within its animal setting. Species differences, specific stress procedures, and the experimental disease models remain important constraints on applying these findings to human stress-related disease susceptibility.

Repeated Stress, Habituation, and Regulatory Dynamics

Repeated stressful encounters may elicit changes in the physiological response over time. Habituation is generally understood as reduced response under repeated exposure to a similar stimulus, although sensitization and sustained responses are also possible. A system's ability to habituate depends on perceived predictability, learning, context, and its regulatory organization. Immune adaptation should therefore be investigated dynamically rather than inferred from a single baseline sample.

Barthel, M.-C., Fricke, K., Muehlhan, M., Vogel, S., & Alexa (2025) conducted a systematic review and meta-analysis of biological responses to repeated psychosocial stress, examining evidence from 47 studies using repeated standardized challenges. The synthesis found clearer and more consistent habituation of hypothalamic–pituitary–adrenal responses than of autonomic and immune markers. This finding cautions against using cortisol adaptation as a proxy for whole-system immune adaptation. Regulatory pathways can respond on different timescales and retain different sensitivities.

Repeated laboratory tasks differ from months or years of naturalistic adversity. A participant can become familiar with an experimental speech or arithmetic challenge while continuing to experience chronic work or family stress. Moreover, attenuation of an immediate hormone spike does not establish recovery from cumulative biological effects, nor does persistent cytokine reactivity necessarily signal imminent clinical disease. The research challenge is to connect repeated exposure and adaptation to meaningful downstream function.

The contemporary evidence supports longitudinal within-person studies that include biological sampling across repeated events, measurement of subjective appraisal, and follow-up of functional immune outcomes. Such designs can distinguish individuals whose responses return to baseline from those with delayed recovery or altered sensitivity. The mechanisms remain hypotheses until they are linked to specific disease endpoints.

Life-Course Inflammation in Contemporary Cohorts

Recent cohort research improves the ability to examine stress across different developmental periods while also demonstrating the limits of retrospective exposure measurement. Hillmann, A. R., Dhingra, R., & Reed, R. G (2024) harmonized information from the Health and Retirement Study and the English Longitudinal Study of Aging, analyzing nearly eight thousand older participants with retrospectively reported stressful life events and later inflammatory measurement.

The study included 7,952 participants and reported associations between cumulative stress exposure and later C-reactive protein. Its analyses also examined the developmental timing of reported events, finding signals for events in young adulthood and midlife. The investigators thus moved beyond the assumption that only childhood can be a particularly consequential period. Yet because participants retrospectively reconstructed event timing and the main outcome was a circulating marker rather than incident disease, memory error and causal ambiguity remain important.

A related quantitative synthesis by Chiang, J. J., Lam, P. H., Chen, E., & Miller, G. E (2022) brought together studies on psychological stress during childhood and adolescence and inflammatory outcomes across the lifespan. It found a small adjusted association overall, with estimates varying by the age at which inflammation was measured. This provides a quantitative boundary for broad claims of biological embedding: associations can be statistically reliable yet modest and sensitive to methodology, exposure definition, and the interval between stress and measurement.

Together, these studies clarify why research should model accumulation and developmental timing separately. Lifetime stress exposure may correlate with inflammation because of continuing environmental conditions, later adversity, changes in health behavior, or persistent physiological regulation. Distinguishing these processes requires repeated contemporaneous measurements, rather than interpreting the final biomarker as a unique signature of earlier psychological events.

These findings also reinforce the distinction between inflammatory correlates and disease susceptibility. Higher C-reactive protein can identify an inflammatory condition or contribute to risk stratification in some settings, but a cohort association involving the marker does not prove that a stressful event caused a specific later diagnosis. Translational designs must specify the disease and its other determinants.

Disease-Specific Synthesis in Multiple Sclerosis

Disease-specific meta-analyses are important because they examine clinical endpoints rather than inferring them from general immune markers. von Drathen, S., Gold, S. M., Peper, J., Rahn, A. C., Ramien (2024) systematically reviewed research on psychological stressors and multiple sclerosis, assessing disease onset, relapse risk, inflammatory activity, and disability progression. Their report identified 30 studies from 26 cohorts encompassing approximately 24,781 cases. The investigators found evidence consistent with a small-to-moderate association for several outcomes, while emphasizing limitations involving case selection and control of confounding.

Multiple sclerosis provides a difficult causal problem: symptoms, uncertainty, treatment burden, and the prospect of relapse can generate stress before a clinically recognized episode. A stress measurement obtained near a relapse may therefore reflect early disease activity rather than a trigger of the event. Stronger designs require prospectively recorded stress exposure, clinically verified relapse or imaging outcomes, and procedures that address the possibility that the disease process itself influenced stress reporting.

The review reported estimates from selected subgroup meta-analyses, including diagnosed stress disorders and multiple sclerosis risk, and studies involving severe collective threat. Such estimates should remain tied to their limited component studies and outcome definitions. They are not universal individual risk multipliers, and observational cohort comparisons cannot alone demonstrate that removing a stressor would prevent disease onset or relapse.

This disease-specific evidence provides a more concrete test of psychoneuroimmune hypotheses than a generic assertion that distress increases inflammation. At the same time, it shows why general mechanisms require careful translation: the immunological pathology, treatment, diagnostic criteria, and time course of multiple sclerosis differ from those of respiratory viruses and wound repair.

New Integrative Reviews and Remaining Research Questions

The recent synthesis by Kiecolt-Glaser, J. K (2026), released online as an advance review, situates decades of psychoneuroimmunology research in the contexts of stress, depression, and close relationships. Its abstract highlights converging evidence concerning infectious illness, vaccination, healing, inflammation, and cellular-aging indicators and discusses newer work on gastrointestinal and microbial pathways. As an integrative review, it maps the accumulated research program; its broader statements should be traced to the primary studies appropriate to each clinical claim.

The current literature points to several research priorities. The first is spatial specificity: distinguishing peripheral blood changes from responses in lymph nodes, tissues, and neural interfaces. The second is temporal specificity: identifying the different adaptation profiles of autonomic, endocrine, and immune systems. The third is causal specificity: measuring stress exposure before candidate mediators and following a defined health endpoint. The fourth is population specificity: testing findings among groups with different immune histories, chronic conditions, social environments, and access to care.

Buric, I (2025) reviewed the psychoneuroimmunology of mindfulness and asked what works, through which pathways, and for whom. This orientation moves the literature toward moderator analysis and mechanism-based intervention evaluation. Promising changes in biomarkers or perceived stress remain separate from reliable clinical reductions in disease, which continue to require targeted trials.

Current neuroimmune models are broader and technically more precise than early notions of stress suppressing immunity. They reveal a highly regulated communication system involving neuronal circuits, immune cells, cytokines, gene expression, and behavior. Their explanatory maturity will be measured by independent replication and successful predictions across specified disease settings. The central question is no longer whether neural and immune systems communicate, which is established, but how particular interactions contribute causally to the onset, severity, repair, and resolution of particular health conditions.

Cardiometabolic Disease and the Limits of Generalization

Chronic inflammation, autonomic regulation, endocrine activity, metabolic processes, and health behavior participate in the development and progression of many cardiometabolic disorders. Because stress can influence several of these pathways, psychoneuroimmunology contributes mechanistic hypotheses about how sustained adversity might affect disease risk. The crucial distinction is between establishing a plausible pathway and demonstrating that a particular psychosocial exposure caused a particular cardiovascular event or metabolic diagnosis.

The framework developed by Miller, G. E., Chen, E., & Parker, K. J (2011) considers how early-life stress could contribute to later chronic disease through behavioral and biological mechanisms, including inflammatory regulation. This life-course account identifies candidate processes that may connect developmental experience with later vulnerability. Its strongest claims concern a research framework and a synthesis of available associations, while direct disease causation requires carefully controlled longitudinal or experimental evidence.

Inflammatory markers can predict aspects of cardiometabolic risk in some epidemiological settings, but their association with stress is insufficient to establish that reducing perceived stress would prevent myocardial infarction or diabetes. Adiposity, dietary patterns, blood pressure, smoking, medication, sleep, and socioeconomic conditions may influence both immune indices and clinical risk. These variables can be confounders or mediators depending on the question. Researchers must therefore distinguish total effects of adversity, direct immune-mediated effects, and effects of lifestyle or structural interventions.

The most informative future studies would combine prospectively measured exposure, multiple inflammatory and endocrine assessments, validated intermediate endpoints, and clinically adjudicated incident disease. Randomized psychosocial programs may be able to test selected intermediate pathways, but long-latency outcomes require substantial duration and adequate statistical power. Observational associations may guide hypothesis selection and population risk research without justifying universal claims about stress as a sufficient cause of cardiometabolic disease.

Psychoneuroimmunology's contribution is explanatory specificity. It directs attention to how sustained stress may influence regulatory systems relevant to chronic illness while recognizing that these disorders arise through multiple interacting biological, behavioral, environmental, and social pathways. The clinical relevance of an immune mechanism is established disease by disease and population by population.

Autoimmune Disease and Inflammatory Disorders

Autoimmune conditions involve inappropriate or dysregulated immune responses toward self-related targets, with disease mechanisms that vary widely across diagnoses. Psychological stress may influence symptom burden, neuroendocrine regulation, and inflammatory responses in some affected populations. However, the initiation of an autoimmune disease, its clinically defined relapse, and a patient's perceived symptom severity are different outcomes. Treating them as equivalent would conceal the actual evidence.

A stress-related change in a circulating inflammatory marker may be mechanistically relevant without proving that it initiates autoimmune pathology. Disease onset depends on genetic susceptibility, environmental exposures, immunological history, and condition-specific processes. Stress exposures may interact with some of these determinants, but a general psychoneuroimmune model cannot substitute for disease-specific prospective cohorts and validated clinical assessments.

Inflammatory disorders also complicate causal direction because active illness is itself stressful and may affect mood, fatigue, sleep, and cognitive function through immune-to-brain signaling. Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W (2008) summarized mechanisms by which inflammation can change behavior and mood. A patient experiencing an inflammatory flare may consequently report elevated distress as a result of the flare, while distress could influence subsequent symptoms or behavior. Temporal measurement is essential for distinguishing these possibilities.

Clinical disease activity should be assessed using appropriately validated measures for the condition concerned. Patient-reported symptoms, physician ratings, imaging, laboratory markers, and pharmacological treatment status each describe different dimensions. Psychological support may improve coping and quality of life while its effect on disease activity remains uncertain. These benefits should be reported on their own terms rather than used as indirect proof of immunological cure.

The responsible position is to investigate condition-specific interactions among psychological context, immune regulation, treatment adherence, and symptoms. Psychoneuroimmunology offers hypotheses about reciprocal regulation, while the evidentiary standards for treatment or prevention remain those of clinical research on the particular disorder.

Depression, Inflammation, and Reciprocal Symptom Pathways

Depression is frequently discussed in psychoneuroimmunology because inflammatory signaling can affect central nervous system processes and because psychological stress can precede some depressive episodes. The relationship is scientifically important precisely because it can operate in both directions and through common causes. A high inflammatory marker in a person with depression does not by itself identify the origin of the illness, nor does the existence of inflammation-related symptoms establish that every depressive condition is inflammatory.

Slavich, G. M., & Irwin, M. R (2014) presented social signal transduction theory to integrate social threat, neural processing, inflammatory signaling, and major depressive disorder. Their account offers a structured set of mechanisms and predictions about circumstances under which social adversity might affect inflammation and mood. It is a theoretical synthesis informed by empirical research, not proof that every element of the pathway operates identically in all patients.

Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W (2008) examined immune-to-brain mechanisms underlying sickness behavior and their potential relation to depressive symptoms. Fatigue, reduced activity, appetite changes, and social withdrawal can accompany immune activation; the similarity of some symptoms to depression makes careful clinical differentiation necessary. Infection, inflammatory disease, medication effects, and sleep disturbances can produce overlapping clinical presentations.

These findings are valuable for clarifying how immune signaling may modify motivation and affect. They also establish a research challenge: the same psychological measure may be influenced by inflammation and may contribute to inflammatory changes through stress-related pathways. Intensive longitudinal designs, randomized interventions with appropriate biological endpoints, and careful assessment of inflammatory illness can help separate these directions.

The scientific interpretation retains the autonomy of both psychological and medical assessment. Psychoneuroimmunology supplies hypotheses about a subset of interacting mechanisms within depressive disorders, not a universal diagnostic test or a stand-alone treatment algorithm.

Cancer, Tumor Immunity, and Claims of Stress Causation

Cancer arises through diverse cellular, genetic, immune, and environmental processes. Because the immune system participates in tumor surveillance and because stress affects selected immune responses, psychoneuroimmune research can generate questions about tumor biology, treatment experience, and supportive care. These questions must be separated from the much stronger claim that psychological stress causes cancer or that stress reduction prevents malignant disease.

Observational studies of distress and cancer outcomes are vulnerable to reverse causation, disease-stage differences, treatment effects, lifestyle confounding, and survivor selection. A cancer diagnosis can produce profound psychological distress and alter sleep, social roles, physical activity, and medication exposure. The temporal association of distress with later outcomes therefore requires careful modeling and disease-specific analysis.

Experimental animal studies of neural signaling and tumor-related processes can be mechanistically informative, but species, tumor model, treatment conditions, and endocrine physiology limit direct translation. In human research, laboratory immune markers are especially insufficient as proxies for cancer incidence or survival. A change in natural killer cell activity or inflammatory gene expression does not establish a meaningful effect on tumor progression without independent clinical evidence.

Psychological interventions in oncology can have important outcomes including distress reduction, coping, fatigue management, and quality of life. Those outcomes deserve independent recognition. Claims about immune-mediated cancer control require rigorously designed oncology trials with clinically meaningful endpoints and appropriate specialist oversight. This research dossier does not recommend substituting psychosocial care for oncological diagnosis or treatment.

The methodological lesson is broader than oncology. When a disease involves immune mechanisms, it can seem intuitively plausible that any measurable change in immunity will modify the disease. Biological plausibility should instead guide precise hypotheses about the relevant immune mechanism, disease stage, and intervention context. The larger and more serious the clinical claim, the more direct its evidentiary requirements.

Randomized Psychosocial Interventions and Immune Function

Intervention research tests whether deliberately changing a psychosocial program can alter a biological outcome. It therefore adds evidence beyond observational associations between stress and immunity. The quality of that evidence depends on random allocation, comparator design, sample size, concealment, adherence, follow-up, laboratory measurement, and the distinction between changes in immune markers and changes in disease.

The systematic review and meta-analysis by Shields, G. S., Spahr, C. M., & Slavich, G. M (2020) synthesized 56 randomized clinical trials with 4,060 participants. Across the included studies, psychosocial interventions were associated with a small-to-moderate improvement in measured immune function, with an overall reported effect size around Hedges g = 0.30. The pooled estimate refers to the measured immune outcomes and the studies meeting review criteria. It cannot be converted into a quantified reduction in disease incidence, hospitalization, or mortality.

The trials differed in intervention approach, duration, outcome domain, and population. Different active components could affect stress appraisal, social support, emotion regulation, sleep, and behavior. A difference in immune marker after treatment does not identify which component was responsible. Trials with inactive controls can also confound specific mechanisms with attention, expectancy, and the benefits of structured participation. Active comparators and mediation designs provide stronger tests of specific psychological pathways.

Measurement choices also matter. Antibody responses, inflammatory markers, cell counts, and immune-stimulated responses have different functional meanings. A positive pooled estimate can conceal changes that differ in direction or clinical significance across domains. The review's contribution is to show that at least some randomized psychosocial programs produce measurable immunological changes, not that they all enhance general immune resistance.

Clinical translation should proceed through endpoint-specific trials. If the hypothesis is reduced respiratory infection, then laboratory-confirmed infection or defined clinical illness must be evaluated. If the hypothesis concerns wound healing, objective tissue outcomes must be followed. If the goal is symptom relief, that is an appropriate and meaningful endpoint in its own right. Intervention research advances when the claim matches what was actually randomized and measured.

Mindfulness Trials, Active Controls, and Interpretation

Mindfulness-based interventions have attracted interest because they may alter attention to stressors, perceived threat, emotion regulation, and behaviors such as sleep or daily practice. Their effects on immune regulation have been studied through circulating cytokines, inflammatory reactions, transcriptional profiles, and other assays. The presence of plausible pathways provides a reason to test these outcomes while leaving open the clinical magnitude and reliability of the effect.

Black, D. S., & Slavich, G. M (2016) systematically reviewed randomized controlled trials of mindfulness meditation and immune-system measures. The review found selected signals of immunological effects while emphasizing differences in trial quality, intervention intensity, samples, and outcomes. The field included small studies and varied laboratory procedures, which restrict the strength of any general conclusion about immune enhancement.

Rosenkranz, M. A., Davidson, R. J., MacCoon, D. G., Sheridan (2013) compared mindfulness-based stress reduction with an active control condition and investigated neurogenic inflammation. The design is particularly useful because it tests a focused biological outcome against a comparator that can absorb some nonspecific effects of structured group participation. Yet a localized inflammatory response following an experimental challenge remains distinct from clinically diagnosed infection or chronic disease.

Blinding participants to behavioral intervention content is difficult, and expectations can influence self-reported stress outcomes. Laboratory personnel and outcome assessors can often be masked, improving the credibility of biological comparisons. Researchers should also report adherence, dropout, intervention fidelity, prespecified immune outcomes, and how they handle multiple simultaneous markers.

Mindfulness interventions may offer psychological benefits even when a given immune endpoint does not change. Conversely, a measurable immune change may occur without demonstrable prevention of illness. The scientific value of these studies lies in refining mechanistic hypotheses and intervention design rather than translating a mixed biomarker literature into broad claims of disease prevention.

Research Programs for Mechanistic and Clinical Progress

Future research needs to connect the relatively well-developed knowledge of neural–immune signaling with more decisive tests of specific disease outcomes. A useful program begins with a target condition and a defined psychosocial exposure, identifies the biological pathway and its temporal sequence, and chooses measurements that discriminate competing explanations. It then evaluates whether a change in the pathway corresponds to a meaningful clinical outcome.

For acute infection, research can use carefully justified challenge protocols, prospective field surveillance, and independent measures of pathogen exposure. For vaccine responses, baseline immunity and antigen-specific follow-up must be incorporated. For wound repair, standardized assessments of tissue closure and relevant clinical conditions can distinguish healing from perceived symptom change. For long-term inflammatory and cardiometabolic disease, repeated exposures, biomarkers, and adjudicated clinical endpoints are needed.

Mechanistic studies should investigate the timing of autonomic activation, glucocorticoid sensitivity, leukocyte redistribution, and inflammatory signaling. Repeated within-person measurements permit separation of stable between-person differences from changes following stress. Multisite protocols, harmonized assays, laboratory quality control, preregistered hypotheses, and complete reporting improve replicability and comparability.

The strongest clinical questions concern pathways that are modifiable, sufficiently specific, and causally upstream of the relevant disease outcome. Randomized stress-focused interventions might change multiple factors simultaneously; factorial trials, active controls, and time-ordered mediation measures could clarify which components matter. Where psychosocial exposures reflect structural conditions, interventions changing work demands or environmental opportunity may be more mechanistically appropriate than instructing individuals to regulate their emotions.

A scientifically mature field will also report heterogeneity. A mechanism may be salient among individuals with a particular immune history, developmental exposure, or disease state but not among others. Prespecified subgroup analyses, transportability evaluations, and careful assessment of treatment effect modification can strengthen the clinical usefulness of psychoneuroimmune theories.

Social Inequality, Ethical Interpretation, and Health Context

Psychological stress is distributed through social conditions including economic insecurity, caregiving obligations, unsafe work, housing instability, discrimination, and limited access to medical care. These conditions may influence biology while also altering pathogen exposure, sleep, nutrition, preventive care, and treatment opportunities. A model emphasizing only individual perception risks overlooking direct environmental causes of disease.

The life-course research reviewed by Miller, G. E., Chen, E., & Parker, K. J (2011) offers a basis for examining how chronic adversity may be biologically embedded through multiple pathways. Such models should be linked to the broader social context rather than interpreted as a direct ranking of individuals by stress tolerance. Differences between groups require analysis of exposure distributions, structural constraints, measurement equivalence, and selection into research samples.

Ethical interpretation begins by avoiding deterministic conclusions from group data. An individual who has experienced severe stress is not thereby destined to develop an infectious or inflammatory disease, and a patient who becomes ill has not thereby failed to manage emotions adequately. Clinical risk is probabilistic and condition-specific. Research on stress-associated physiology should inform the study of preventable exposures and supportive environments without converting association into blame.

Privacy and participant protection are relevant when studies collect sensitive details about adversity, employment, relationships, or early trauma. Researchers should distinguish data needed to test causal mechanisms from unnecessary personal histories, minimize participant burden, and ensure that biological findings are communicated with appropriate uncertainty. The presence of a biomarker association must not be used to claim a personal diagnostic profile without clinical validation.

Psychoneuroimmunology can contribute to public-health reasoning by identifying how environmental demands become incorporated in host regulation. That contribution is strongest when biological, behavioral, and structural explanations are jointly examined and interventions are evaluated against actual outcomes.

Human–Artificial Relations and Psychoneuroimmune Questions in the Artificial Era

The Artificial Era introduces new environments in which people receive information, social feedback, reminders, companionship, and task support from artificial systems. These interactions may alter perceived support, cognitive workload, exposure to stressful content, or adherence to daily routines. Their possible psychoneuroimmune relevance arises through human psychological and behavioral pathways, which are available for empirical study. A conversational artificial agent does not require an assumed biological immune system for its social effects on human stress to become a testable research question.

A research program could examine whether reliable artificial assistance changes repeated subjective stress measurements, sleep patterns, autonomic responses, and selected inflammatory outcomes under controlled conditions. The design would need to distinguish artificial assistance from ordinary digital reminders, social contact, and expectancy effects. It would also need to measure potentially adverse effects including dependence, disrupted sleep, intrusive notifications, or misleading advice.

The distinction between immediate emotional regulation and clinical immunity remains decisive. A person may report feeling calmer after interacting with an artificial system, but that observation does not establish improved vaccine response, faster healing, or reduced viral susceptibility. Separate biological and clinical measurements are required for each proposed consequence. The hypotheses are grounded in existing stress and social-support research while awaiting dedicated replication in human–Artificial settings.

Artificial systems may also assist research operations by structuring diaries, detecting missing data, supporting longitudinal follow-up, and improving access to scientific information. These applications carry risks of measurement bias, algorithmic error, privacy intrusion, and unequal access. Research governance must evaluate those issues independently from claims about any biological benefit.

Within this dossier, Artificial Era research is a forward-looking extension of the study of human psychoneuroimmune regulation. Its scientific standing rests on operational definitions, controlled comparisons, transparent data, and clinically specified endpoints.

Conclusion

Psychoneuroimmunology establishes a research field in which psychological and social experience, nervous-system activity, endocrine signals, immune regulation, and behavior are investigated as interacting processes. Foundational conditioning studies demonstrated learned modulation of measured immunity in animals; subsequent work described reciprocal immune-to-brain signaling and differentiated acute from chronic stress responses. Controlled viral-challenge studies connected prospectively measured psychological stress with susceptibility to specific respiratory illnesses, while vaccine-response and wound-healing research provided additional functional outcomes.

The cumulative literature supports a structured conclusion. Psychological stress can be associated with measurable differences in immune regulation, and particular experimental and prospective designs provide meaningful evidence of altered host responses under specified conditions. The direction and interpretation of immune changes depend on stress duration, assay type, tissue, timing, immune history, and clinical endpoint. Acute mobilization, altered glucocorticoid sensitivity, inflammatory signaling, sleep, and social behavior are plausible and partially supported pathways that require independent testing when used to explain a specific disease.

The major scientific boundary concerns the translation from biomarkers and mechanisms to disease prevention or causation. An inflammatory signal is not a general diagnosis of impaired immunity. A randomized intervention that changes selected immune measures does not automatically reduce infection incidence or chronic-disease risk. Observational associations of adversity with cancer, cardiovascular disease, or autoimmune illness require disease-specific causal appraisal and cannot be generalized from laboratory stress studies.

The durable contribution of the field is a methodology for testing the biological consequences of meaningful environments through specified, measurable pathways. Its next advances will come from temporally precise experiments, objective clinical outcomes, independent replication, integrative causal models, and research sensitive to population and social context. The Artificial Era extends the domain of potential human stressors and supports, creating additional research questions while leaving their clinical answers to rigorous empirical investigation.

References

  • Ader, R., & Cohen, N. (1975). Behaviorally conditioned immunosuppression. Psychosomatic Medicine, 37(4), 333–340. https://doi.org/10.1097/00006842-197507000-00007
  • Barthel, M.-C., Fricke, K., Muehlhan, M., Vogel, S., & Alexander, N. (2025). Habituation of the biological response to repeated psychosocial stress: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews, 169, 105996. https://doi.org/10.1016/j.neubiorev.2024.105996
  • Besedovsky, H., Sorkin, E., Felix, D., & Haas, H. (1977). Hypothalamic changes during the immune response. European Journal of Immunology, 7(5), 323–325. https://doi.org/10.1002/eji.1830070516
  • Besedovsky, H., Sorkin, E., Keller, M., & Müller, J. (1975). Changes in blood hormone levels during the immune response. Proceedings of the Society for Experimental Biology and Medicine, 150(2), 466–470. https://doi.org/10.3181/00379727-150-39057
  • Black, D. S., & Slavich, G. M. (2016). Mindfulness meditation and the immune system: A systematic review of randomized controlled trials. Annals of the New York Academy of Sciences, 1373(1), 13–24. https://doi.org/10.1111/nyas.12998
  • Buric, I. (2025). Psychoneuroimmunology of mindfulness: What works, how it works, and for whom? Brain, Behavior, & Immunity - Health, 46, 101022. https://doi.org/10.1016/j.bbih.2025.101022
  • Chiang, J. J., Lam, P. H., Chen, E., & Miller, G. E. (2022). Psychological stress during childhood and adolescence and its association with inflammation across the lifespan: A critical review and meta-analysis. Psychological Bulletin, 148(1–2), 27–66. https://doi.org/10.1037/bul0000351
  • Cohen, S., Doyle, W. J., Skoner, D. P., Rabin, B. S., & Gwaltney, J. M., Jr. (1997). Social ties and susceptibility to the common cold. JAMA, 277(24), 1940–1944. https://doi.org/10.1001/jama.1997.03540480040036
  • Cohen, S., Frank, E., Doyle, W. J., Skoner, D. P., Rabin, B. S., & Gwaltney, J. M., Jr. (1998). Types of stressors that increase susceptibility to the common cold in healthy adults. Health Psychology, 17(3), 214–223. https://doi.org/10.1037/0278-6133.17.3.214
  • Cohen, S., Janicki-Deverts, D., Doyle, W. J., Miller, G. E., Frank, E., Rabin, B. S., & Turner, R. B. (2012). Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk. Proceedings of the National Academy of Sciences, 109(16), 5995–5999. https://doi.org/10.1073/pnas.1118355109
  • Cohen, S., Tyrrell, D. A. J., & Smith, A. P. (1991). Psychological stress and susceptibility to the common cold. New England Journal of Medicine, 325(9), 606–612. https://doi.org/10.1056/NEJM199108293250903
  • Cohen, S., Tyrrell, D. A. J., & Smith, A. P. (1993). Negative life events, perceived stress, negative affect, and susceptibility to the common cold. Journal of Personality and Social Psychology, 64(1), 131–140. https://doi.org/10.1037/0022-3514.64.1.131
  • Cole, S. W. (2014). Human social genomics. PLOS Genetics, 10(8), e1004601. https://doi.org/10.1371/journal.pgen.1004601
  • Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008). From inflammation to sickness and depression: When the immune system subjugates the brain. Nature Reviews Neuroscience, 9(1), 46–56. https://doi.org/10.1038/nrn2297
  • Dhabhar, F. S. (2014). Effects of stress on immune function: The good, the bad, and the beautiful. Immunologic Research, 58(2–3), 193–210. https://doi.org/10.1007/s12026-014-8517-0
  • Epel, E. S., Blackburn, E. H., Lin, J., Dhabhar, F. S., Adler, N. E., Morrow, J. D., & Cawthon, R. M. (2004). Accelerated telomere shortening in response to life stress. Proceedings of the National Academy of Sciences, 101(49), 17312–17315. https://doi.org/10.1073/pnas.0407162101
  • Glaser, R., & Kiecolt-Glaser, J. K. (2005). Stress-induced immune dysfunction: Implications for health. Nature Reviews Immunology, 5(3), 243–251. https://doi.org/10.1038/nri1571
  • Gouin, J.-P., & Kiecolt-Glaser, J. K. (2011). The impact of psychological stress on wound healing: Methods and mechanisms. Immunology and Allergy Clinics of North America, 31(1), 81–93. https://doi.org/10.1016/j.iac.2010.09.010
  • Hillmann, A. R., Dhingra, R., & Reed, R. G. (2024). Stressful life events across the lifespan and inflammation: An integrative data analysis. Brain, Behavior, & Immunity - Health, 41, 100861. https://doi.org/10.1016/j.bbih.2024.100861
  • Irwin, M. R., & Cole, S. W. (2011). Reciprocal regulation of the neural and innate immune systems. Nature Reviews Immunology, 11(9), 625–632. https://doi.org/10.1038/nri3042
  • Kiecolt-Glaser, J. K. (2026). Four decades of stress, depression, and close relationships: Lessons from psychoneuroimmunology. Annual Review of Psychology, advance online publication (Vol. 78, in press). https://doi.org/10.1146/annurev-psych-020226-033326
  • Kiecolt-Glaser, J. K., Glaser, R., Gravenstein, S., Malarkey, W. B., & Sheridan, J. (1996). Chronic stress alters the immune response to influenza virus vaccine in older adults. Proceedings of the National Academy of Sciences, 93(7), 3043–3047. https://doi.org/10.1073/pnas.93.7.3043
  • Kiecolt-Glaser, J. K., Marucha, P. T., Malarkey, W. B., Mercado, A. M., & Glaser, R. (1995). Slowing of wound healing by psychological stress. The Lancet, 346(8984), 1194–1196. https://doi.org/10.1016/S0140-6736(95)92899-5
  • Kiecolt-Glaser, J. K., McGuire, L., Robles, T. F., & Glaser, R. (2002). Psychoneuroimmunology: Psychological influences on immune function and health. Journal of Consulting and Clinical Psychology, 70(3), 537–547. https://doi.org/10.1037/0022-006X.70.3.537
  • Leunig, A., Gianeselli, M., Russo, S. J., & Swirski, F. K. (2025). Connection and communication between the nervous and immune systems. Nature Reviews Immunology, 25, 912–933. https://doi.org/10.1038/s41577-025-01199-6
  • Marsland, A. L., Walsh, C., Lockwood, K., & John-Henderson, N. A. (2017). The effects of acute psychological stress on circulating and stimulated inflammatory markers: A systematic review and meta-analysis. Brain, Behavior, and Immunity, 64, 208–219. https://doi.org/10.1016/j.bbi.2017.01.011
  • Miller, G. E., Chen, E., & Parker, K. J. (2011). Psychological stress in childhood and susceptibility to the chronic diseases of aging: Moving toward a model of behavioral and biological mechanisms. Psychological Bulletin, 137(6), 959–997. https://doi.org/10.1037/a0024768
  • Miller, G. E., Cohen, S., & Ritchey, A. K. (2002). Chronic psychological stress and the regulation of pro-inflammatory cytokines: A glucocorticoid-resistance model. Health Psychology, 21(6), 531–541. https://doi.org/10.1037/0278-6133.21.6.531
  • Nusslock, R., & Miller, G. E. (2016). Early-life adversity and physical and emotional health across the lifespan: A neuroimmune network hypothesis. Biological Psychiatry, 80(1), 23–32. https://doi.org/10.1016/j.biopsych.2015.05.017
  • Poller, W. C., Downey, J., Mooslechner, A. A., Khan, N., Li, L., Chan, C. T., McAlpine, C. S., Xu, C., Kahles, F., He, S., Janssen, H., Mindur, J. E., Singh, S., Kiss, M. G., Alonso-Herranz, L., Iwamoto, Y., Kohler, R. H., Wong, L. P., Chetal, K.,. Swirski, F. K. (2022). Brain motor and fear circuits regulate leukocytes during acute stress. Nature, 607(7919), 578–584. https://doi.org/10.1038/s41586-022-04890-z
  • Prather, A. A., Janicki-Deverts, D., Hall, M. H., & Cohen, S. (2015). Behaviorally assessed sleep and susceptibility to the common cold. Sleep, 38(9), 1353–1359. https://doi.org/10.5665/sleep.4968
  • Rosenkranz, M. A., Davidson, R. J., MacCoon, D. G., Sheridan, J. F., Kalin, N. H., & Lutz, A. (2013). A comparison of mindfulness-based stress reduction and an active control in modulation of neurogenic inflammation. Brain, Behavior, and Immunity, 27(1), 174–184. https://doi.org/10.1016/j.bbi.2012.10.013
  • Segerstrom, S. C., & Miller, G. E. (2004). Psychological stress and the human immune system: A meta-analytic study of 30 years of inquiry. Psychological Bulletin, 130(4), 601–630. https://doi.org/10.1037/0033-2909.130.4.601
  • Shields, G. S., Spahr, C. M., & Slavich, G. M. (2020). Psychosocial interventions and immune system function: A systematic review and meta-analysis of randomized clinical trials. JAMA Psychiatry, 77(10), 1031–1043. https://doi.org/10.1001/jamapsychiatry.2020.0431
  • Slavich, G. M., & Irwin, M. R. (2014). From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. Psychological Bulletin, 140(3), 774–815. https://doi.org/10.1037/a0035302
  • Steptoe, A., Hamer, M., & Chida, Y. (2007). The effects of acute psychological stress on circulating inflammatory factors in humans: A review and meta-analysis. Brain, Behavior, and Immunity, 21(7), 901–912. https://doi.org/10.1016/j.bbi.2007.03.011
  • Vedhara, K., Cox, N. K., Wilcock, G. K., Perks, P., Hunt, M., Anderson, S., Lightman, S. L., & Shanks, N. M. (1999). Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination. The Lancet, 353(9153), 627–631. https://doi.org/10.1016/S0140-6736(98)06098-X
  • von Drathen, S., Gold, S. M., Peper, J., Rahn, A. C., Ramien, C., Magyari, M., Hansen, H.-C., Friede, T., & Heesen, C. (2024). Stress and multiple sclerosis: Systematic review and meta-analysis of the association with disease onset, relapse risk and disability progression. Brain, Behavior, and Immunity, 120, 620–629. https://doi.org/10.1016/j.bbi.2024.06.004
  • Wheeler, M. A., & Quintana, F. J. (2025). The neuroimmune connectome in health and disease. Nature, 638(8050), 333–342. https://doi.org/10.1038/s41586-024-08474-x